Profil
Mark J.
Taisey is currently the Senior VP-Global Regulatory Affairs & Strategy at Amgen, Inc. He previously worked as the Chairman-Regulatory Steering Group at Pharmaceutical Research & Manufacturers of America from 2019 to 2020, and as an Executive Director at Pfizer Inc. from 2002 to 2007.
Mr. Taisey completed his undergraduate degree at Rochester Christian University.
Aktive Positionen von Mark J. Taisey
| Unternehmen | Position | Beginn |
|---|---|---|
| AMGEN INC. | General Counsel | 01.01.2014 |
Ehemalige bekannte Positionen von Mark J. Taisey
| Unternehmen | Position | Ende |
|---|---|---|
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Corporate Officer/Principal | 01.01.2020 |
| PFIZER, INC. | Director/Board Member | 01.01.2007 |
Ausbildung von Mark J. Taisey
| Rochester Christian University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
